Arcalyst 220MG VIL
Ended Awarded Last action
- Contract number
- 36C26025F0112
- Awardee
-
Kiniksa Pharmaceuticals (Uk), LTD. UEI HBHWNLNMHSV5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $208,833
Award facts
- Contract value 100% obligated
- $208,832.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $191 | |
| Funding Only Action | $1,908 | |
| Original award | $206,734 |
About this award
This federal contract award is for the delivery of the pharmaceutical product ARCALYST 220MG VIL to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20. The $208,832.99 firm fixed-price contract was awarded to Kiniksa Pharmaceuticals (UK), LTD., a foreign-owned, for-profit biopharmaceutical company. The contract was issued against Kiniksa's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract and does not have a set-aside designation, indicating open competition. Kiniksa Pharmaceuticals holds two significant indefinite-delivery vehicles (IDVs) that facilitate its federal contracting capabilities, including a $5.9 million single-award Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for supplying Arcalyst. This contract supports healthcare programs for veterans, with delivery orders specifically targeting VA medical facilities.
Quick answers
Who was awarded contract 36C26025F0112?
36C26025F0112 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 15, 2024.
How much is contract 36C26025F0112 worth?
The government has obligated $208,833 on 36C26025F0112.
Is contract 36C26025F0112 an order under another contract?
Yes. 36C26025F0112 is a delivery order under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0112 competed?
The extent of competition for 36C26025F0112 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award